Stepaniuk Peter, Vostretsova Kateryna, Kanani Amin
1Department of Internal Medicine, University of British Columbia, Vancouver, BC Canada.
2Division of Allergy and Immunology, University of British Columbia, Suite 207 - 3195 Granville Street, Vancouver, BC V5R 3V8 Canada.
Allergy Asthma Clin Immunol. 2018 Dec 18;14:85. doi: 10.1186/s13223-018-0310-5. eCollection 2018.
Cold-induced urticaria is a significant condition, especially among young females. Despite the morbidity of this disease, studies that fully characterize the disease are limited.
We analyzed the characteristics of patients diagnosed with cold-induced urticaria at a community-based allergy practice in Vancouver, BC, Canada between 2003 and 2016. Detailed patient history, diagnostic measures and treatment were evaluated.
A total of 50 patients were found to have active cold-induced urticaria with a median age of 28.5 (range 2-67) years and 35 patients (70%) were female. 16 patients (32%) had co-occurring physical urticarias while 26 patients (52%) had secondary allergic diagnoses and 3 patients (6%) were thought to have a provoking factor. Of those with a clinical history of suspected cold-induced urticaria that were evaluated with ice cube testing, a positive test was obtained in 84.7% of patients. Treatment was largely with non-sedating antihistamines, with the majority of patients receiving this modality.
Cold-induced urticaria is a complex disease with significant overlap with other chronic inducible urticarias and other allergic diseases. Diagnostic testing shows inconsistent results and the mainstay of treatment consists of non-sedating antihistamines, with other options available for those who do not respond.
寒冷性荨麻疹是一种重要的疾病,尤其是在年轻女性中。尽管该疾病发病率较高,但全面描述该疾病的研究有限。
我们分析了2003年至2016年期间在加拿大不列颠哥伦比亚省温哥华一家社区过敏诊所被诊断为寒冷性荨麻疹的患者的特征。评估了详细的患者病史、诊断措施和治疗情况。
共发现50例活动性寒冷性荨麻疹患者,中位年龄为28.5岁(范围2 - 67岁),35例(70%)为女性。16例(32%)患者同时患有物理性荨麻疹,26例(52%)有继发性过敏诊断,3例(6%)被认为有诱发因素。在那些有疑似寒冷性荨麻疹临床病史并接受冰块试验评估的患者中,84.7%的患者试验呈阳性。治疗主要使用非镇静性抗组胺药,大多数患者接受这种治疗方式。
寒冷性荨麻疹是一种复杂的疾病,与其他慢性诱发性荨麻疹和其他过敏性疾病有显著重叠。诊断测试结果不一致,治疗的主要方法是使用非镇静性抗组胺药,对于无反应者还有其他选择。